Recall: Baxter INTRALIPID 20% IV Fat Emulsion, 100 ML
On 2017-10-05, the FDA announced that Baxter International is conducting a recall on INTRALIPID 20% IV Fat Emulsion, 100 ML due to a possible . The recalled products were sold under the brand name(s) Baxter during an unspecified time period throughout the regions shown in the map below.
In recent months, there have been 2 drugs recalls due to potential undetermined hazard, including oxytocin, eliquis (apixaban) 5 mg tablets and more. Additionally, there have been 21 drug and medical device recalls due to other health hazards as well as 79 food recalls.
Company Contact Information:
Name: Baxter International
Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.
Detailed Recall Information
Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.
Product Description: INTRALIPID 20% IV Fat Emulsion, 100 mL
Brand Name(s): Baxter
Reason for Recall: Product exposed to subfreezing temperatures
Official Recall Date: 2017-10-05
Additional information provided by the FDA.gov:
Baxter International Inc. announced today it is voluntarily recalling one shipment from a single lot of INTRALIPID 20% IV Fat Emulsion, 100 mL, distributed between 8/11/17 and 8/31/17 to hospitals and healthcare providers in the United States, to the user level. The product has been exposed to subfreezing temperatures during transit to a distribution facility. The subfreezing temperature is outside of the acceptable storage range listed on the product labeling. Other shipments of this lot are not affected by this issue. Read More.
More information may be available at FDA.gov
Latest Safety Recalls
Select image for details, including additional styles.
Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.